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Abstract
The pathogenesis of systemic vasculitis is complex and is likely to involve many mechanisms.
There is a growing body of evidence that T cells may contribute to the pathogenesis of anti-
neutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Predominantly, T cells and
monocytes are found in inflammatory infiltrates in patients with Wegener’s granulomatosis
(WG). The production of ANCA appears to be T-cell-dependent. T lymphocytes from the
peripheral blood of patients with ANCA-associated vasculitis have been shown to proliferate
in response to proteinase 3 (PR3). These and other findings outlined in this review indicate
T-cell involvement, although further studies are still needed to elucidate the exact
contribution of T cells to the pathogenesis of systemic vasculitis.
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aa = amino acid; ANCA = anti-neutrophil cytoplasmic antibodies; HLA = human leucocyte antigen; IFN = interferon; Ig = immunoglobulin; IL = inter-
leukin; PR3 = proteinase 3; TCR = T-cell receptor; Th = T helper; V = variable region; WG = Wegener’s granulomatosis.
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Introduction
Systemic vasculitis is characterised by the inflammation
and necrosis of blood-vessel walls. This leads to circula-
tory compromise and ischaemia in the organs supplied by
the damaged vessels. ANCAs with specificity for PR3 are
found in many patients with WG. The evidence that T cells
are involved in the pathogenesis of systemic vasculitis is
outlined in this review.
In vivo evidence for T-cell involvement in
systemic vasculitis
As long ago as 1983, T cells and monocytes were found
to be the predominant cell types in inflammatory vascular
and perivascular lymphoid infiltrates in WG, suggesting
these cells play an important role in this disease [1]. The
predominant IgG subclasses of ANCA in patients with
WG are IgG1 and IgG4 [2]. Isotype switching from IgG1
to IgG4 is dependent on repeated antigenic stimulation
and also on T-cell cytokines such as IL-4, which suggests
that the production of the antibodies is T-cell-dependent.
Furthermore, in patients with WG, the concentrations of
soluble IL-2 receptor, which is a marker of T-cell activation,
correlate well with disease activity [3].
In vitro analyses of peripheral blood T cells
Studies of the potential for peripheral blood T cells from
patients with ANCA-associated systemic vasculitis to
respond to PR3 have given conflicting results. Earlyhttp://arthritis-research.com/content/2/4/260
studies suggested that T-cell proliferative responses to
neutrophil antigens were present in patients but not in
controls [4], although the patient numbers used were very
small. Some more recent studies have shown little or no
difference in T-cell reactivity to PR3 between patients and
controls [5,6]. The lack of difference may have been due
to the crude nature of the PR3 antigen preparation used
[6] or to the use of detergents during the isolation and
purification of PR3 [5,7]. Responses by peripheral blood T
cells to PR3 purified without detergent were seen in
patients tested during the acute stage of the disease, and
to a lesser extent in normal and disease controls [8]. The
largest study looking at T-lymphocyte responses to ANCA
antigens in patients with ANCA-associated systemic vas-
culitis was in 45 patients at all stages of disease – active
and remitting, treated and untreated – and in 19 normal
and disease controls [9•]. Proliferative responses to PR3
purified without detergent were seen using T cells from
vasculitis patients, whether in remission or at any stage of
disease activity, and to a lesser degree in controls [9•].
Recent studies have confirmed T-lymphocyte responses
to PR3 in patients with ANCA-associated vasculitis (AR
Clayton, unpublished data). T cells from healthy individuals
may also proliferate to PR3, reflecting responses from T
cells that have previously encountered this self-antigen
and that are under regulatory control under normal condi-
tions in vivo. The PR3 epitopes that are presented to T
cells, whether in patients or normal individuals, have not
been defined. One study found significant responses from
a single patient to three PR3 peptides: amino acid (aa)
1–26, aa 161–186, and aa 221–246 [9•].
T-cell receptor (TCR) V gene usage
Patients with vasculitides often have a disturbed periph-
eral blood T-cell repertoire, with a high frequency of T-cell
expansions. This may be due to superantigens (usually
microbial proteins), which cause dramatic expansions of T
lymphocytes bearing a particular variable-region (V)b gene
product [10]. Conventional antigens, on the other hand,
usually stimulate T cells bearing several V gene products.
One study has looked at the number of cells expressing
certain Va and Vb gene segments in the CD4+ and CD8+
subsets of 11 patients with WG or polyarteritis and in 19
controls [11]. In the patient group, abnormal expansions of
T cells using particular TCR Va or Vb gene products were
found (especially in the CD4+ subset) compared with T-
cell expansions in healthy individuals. Another study found
a significant increase in the mean percentage expression
of the Vb 2.1 gene in the peripheral blood of vasculitis
patients compared with controls [12]. There were also
increases in the expression of Vb 3, 13, and 14 in vasculi-
tis patients compared with controls. More recently,
workers decided to characterise more closely the TCR of
T-cell populations from human leucocyte antigen (HLA)-
typed patients with WG or polyarteritis [13••]. These
workers found a common TCR BV8 b chain sequence in
the CD4+ subsets of four unrelated patients with vasculitis
who were positive for the HLA-DRb1*0401 allele, corre-
sponding to active disease and/or BV8+ CD4+ T-cell
expansions. Such T cells were not found in age- and HLA-
matched controls who had rheumatoid arthritis. The
researchers suggested that patients with systemic vasculi-
tis have been exposed to a common antigen, which has
elicited a cellular immune response.
Cytokines and costimulation
Wegener’s granulomatosis, as the name suggests,
involves granulomatous inflammation. The profile of
cytokine secretion by T cells derived from tissue with gran-
ulomatous inflammation (nasal mucosal biopsy speci-
mens) or from an area close to the site of granulomatous
inflammation (bronchiolar lavage fluid) have been analysed
and compared with results from peripheral blood T cells
[14•]. A T-helper (Th)1 pattern of cytokines predominates
in T cells derived from the tissue of granulomatous inflam-
mation and bronchiolar lavage fluid, as well as in T cells
from peripheral blood. Other studies of peripheral blood T
cells from patients with WG have previously shown that
these cells exhibit increased secretion of interferon (IFN)g
but not of IL-4, IL-5, or IL-10, suggesting a Th1 response
in the periphery [15••].
Activation of T cells involving cytokine production and pro-
liferation requires at least one costimulatory signal. The
expression of CD28 on T cells has been reported to be
significantly lower in patients with WG than in healthy con-
trols, while expression of B7-1 and B7-2 on T cells acti-
vated in vitro is increased in these patients [16•]. CD28
costimulation promotes the production of Th2 cytokines
[17,18]. In the absence of this costimulation, cells are not
primed to produce Th2 cytokines and so they ‘default’ to
the Th1 subset, independently of the presence of exoge-
nous cytokines [19]. If, as discussed, a Th1 cytokine
profile predominates in the granuloma and peripheral
blood of patients with WG [14], this lack of CD28 costim-
ulation in such patients may augment the development of
the Th1 pattern. Th1 cells are more dependent on B7 cos-
timulation for their activation than Th2 cells are [20], and
therefore the increased expression of B7 on T cells from
patients with WG may also promote the Th1 immunoreac-
tion leading to granuloma formation and necrotising
inflammation [16•].
Conclusion
T cells appear to be involved in the pathogenesis of sys-
temic vasculitis, but their specific role is still uncertain. The
immunopathological process is T-cell-driven and ANCA
production appears to be T-cell-dependent. Peripheral
blood T-cell responses to PR3-ANCA are seen in patients
and to a lesser extent in controls. Selection of particular
TCRs in patients with systemic vasculitis may suggest the
existence of a specific vasculitis-associated T-cell antigen.Arthritis Research    Vol 2 No 4 Clayton and Savage
Understanding the mechanisms resulting in loss of toler-
ance in patients with systemic vasculitis may be of impor-
tance for prognosis and the development of new
immunotherapies.
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